Physician profile
Prasanth Gogineni
NPI 1376641902
$794.97
in general payments reported to CMS, 2019-2025
12 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $172 · 2024: $240 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $155.27 | 2024-2025 | |
| Abbvie INC. | $145.98 | 2023-2025 | |
| Lilly USA, LLC | $120.54 | 2024-2025 | Zepbound, Mounjaro |
| Esperion Therapeutics, INC. | $63.23 | 2023-2024 | Nexletol |
| Abbott Laboratories | $59.16 | 2023 | Proclaim |
| Exact Sciences Corporation | $53.33 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $47.02 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $42.97 | 2024 | Farxiga |
| Tms Neurohealth Centers INC. | $29.85 | 2025 | Tms Neurohealth Centers INC. |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.03 | 2025 | Jardiance |
| Amgen INC. | $25.99 | 2025 | Otezla, Repatha |
| Agepha Pharma Fz LLC | $23.60 | 2024 | Lodoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prasanth Gogineni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.